Sutures & Sectors: HTEC Has Been Operating Since 2019

Fire up the fog machines and spin up the servo motors (and maybe a few celebratory beeps and boops)—the ROBO Global Healthcare Technology and Innovation ETF (HTEC) just turned six!

That’s six years of championing the cutting edge of healthcare, tracking the pioneers transforming medicine through robotics, AI, diagnostics, genomics, and beyond.

And yes, we’re throwing a full-on robo party in its honor.

Since its launch in 2019, the ROBO Global Healthcare Technology and Innovation ETF (HTEC) has been laser-focused on a singular mission: capturing the companies reshaping how we prevent, diagnose, and treat disease. We're talking surgical robots, next-gen diagnostics, wearable health tech, and biotech breakthroughs that sound like they came straight out of a sci-fi movie—but are very real, and very investable.

HTEC’s strategy goes far beyond your average healthcare exposure. It aims to be a finely tuned, research-driven approach built by industry experts who know the pulse of the sector better than anyone (pun fully intended). With a global scope and thematic precision, HTEC puts the spotlight on innovators across 9 key subsectors—from medical instruments and data analytics to regenerative medicine and precision medicine.

We raise a glass (or a motorized arm) to a fund that’s been at the intersection of technology and health since day one.

So, as we blow out the (virtual) candles and let the robots DJ, here’s what we’re celebrating:

• 🤖 A portfolio of cutting-edge healthcare innovators
• 🧬 Exposure to the technologies rewriting the rules of medicine
• 🌎 A global approach to tracking the pulse of healthcare disruption
• 🎉 And a strategy that keeps its finger on the digital pulse

Here’s to the robots saving lives, the tech improving outcomes, and the ETF that lets you invest in all of it. Happy 6th birthday, HTEC—you’ve earned every blinking LED on your party hat.

Want to learn more about the HTEC ETF?

Tap in and join the robot dance party. ROBO Global Healthcare Technology and Innovation ETF (HTEC) 

ROBO Global Disclosures:

Carefully consider the Funds’ investment objectives, risk factors, charges and expenses before investing. This and additional information can be found on the Funds' full or summary prospectuses, which may be obtained at www.roboglobaletfs.com. Read the prospectus carefully before investing.

Investing involves risk, including the possible loss of principal. International investments may also involve risk from unfavorable fluctuations in currency values, differences in generally accepted accounting principles, and from economic or political instability. Emerging markets involve heightened risks related to the same factors as well as increased volatility and lower trading volume. Narrowly focused investments and investments in smaller companies typically exhibit higher volatility. There is no guarantee the fund will achieve its stated objective. HTEC is non-diversified.

The liquidity of the A-shares market and trading prices of A-shares could be more severely affected than the liquidity and trading prices of other markets because the Chinese government restricts the flow of capital into and out of the A-shares market. The funds may experience losses due to illiquidity of the Chinese securities markets or delay or disruption in execution or settlement of trades.

The risks associated with investments in Robotics and Automation Companies include, but are not limited to, small or limited markets for such securities, changes in business cycles, world economic growth, technological progress, rapid obsolescence, and government regulation. Robotics and Automation Companies, especially smaller, start-up companies, tend to be more volatile than securities of companies that do not rely heavily on technology. Rapid change to technologies that affect a company's products could have a material adverse effect on such company's operating results. Robotics and Automation Companies may rely on a combination of patents, copyrights, trademarks and trade secret laws to establish and protect their proprietary rights in their products and technologies. There can be no assurance that the steps taken by these companies to protect their proprietary rights will be adequate to prevent the misappropriation of their technology or that competitors will not independently develop technologies that are substantially equivalent or superior to such companies' technology.

The risks associated with Artificial Intelligence (AI) Companies include, but are not limited to, small or limited markets, changes in business cycles, world economic growth, technological progress, rapid obsolescence, and government regulation. Rapid change to technologies that affect a company’s products could have a material adverse effect on such company’s operating results. AI Companies also rely heavily on a combination of patents, copyrights, trademarks and trade secret laws to establish and protect their proprietary rights in their products and technologies. There can be no assurance that the steps taken by these companies to protect their proprietary rights will be adequate to prevent the misappropriation of their technology or that competitors will not independently develop technologies that are substantially equivalent or superior to such companies’ technology. AI Companies typically engage in significant amounts of spending on research and development, and there is no guarantee that the products or services produced by these companies will be successful.

The risks associated with Medical Technology Companies include, but are not limited to, small or limited markets for such securities, changes in business cycles, world economic growth, technological progress, rapid obsolescence, and government regulation.

The Fund is distributed by SEI Investments Distribution Co. (SIDCO) 1 Freedom Valley Drive, Oaks, PA, 19456